Premenstrual syndrome. Premenstrual tension syndrome
Conditions
Interventions
Intervention 1: Daily consumption of Vitamin D( Containing 200 mg of powdered vitamin D of MERK company, prepared by Isfahan Faculty of Pharmacy )or vitamin E(Containing 100 mg of powdered vitamin E o
Treatment - Drugs
Placebo
Daily consumption of Vitamin D( Containing 200 mg of powdered vitamin D of MERK company, prepared by Isfahan Faculty of Pharmacy )or vitamin E(Containing 100 mg of powdered vitamin E of MERK company,
Daily consumption of the placebo(Containing of Starch, prepared by Isfahan Faculty of Pharmacy) from the first day of the menstrual cycle until the first day of the next menstrual cycle for 2 cycles.
Sponsors
Vice chancellor for research,Isfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: being 15-45 years old; having regular menstrual cycle; not being affected by depression or anxiety; not having an acute or chronic disease; not taking medicines or supplements, and not taking regular exercise The exclusion criteria: pregnancy; willingness to use hormonal contraceptive methods or taking any hormonal treatment; not taking the drug or not filling out the forms regularly; and unwillingness to continue the treatment.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean score of syndrome. Timepoint: 2 months before and 2 montha after. Method of measurement: Daily Rating Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effect. Timepoint: 2 months after intervention. Method of measurement: Questionaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Ebrahimi
Shahrood University Of MedicalSciences.
Outcome results
None listed